In line with this, biglycan was recently shown to modulate gastric cancer aggressive features as cell survival, migration, and angiogenesis and biglycan knockout gastric cancer cells showed increased levels of PARP1 (Poly [ADP-ribose] polymerase 1) and Caspase 3 cleavage (200). This evidence concerns the gene PARP1 and gastric cancer.